Back to NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO

BCLIBCLI
4 quarters

Position history for NORTHWESTERN MUTUAL WEALTH MANAGEMENT CONORTHWESTERN MUTUAL WEALTH MANAGEMENT CO's holdings in BrainStorm Cell Therapeutics In

No. Northwestern Mutual Wealth Management exited its BCLI (BrainStorm Cell Therapeutics in) position in Q3 2025. Its Q2 2025 13F listed 10 shares worth $11. Northwestern Mutual Wealth Management first reported BCLI in Q4 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$23

Total Shares Change

-10

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$0.70
0
2025-Q2
Unchanged
10
0.0%
$110.0%$1.06
0
2025-Q1
Unchanged
10
0.0%
$130.0%$1.19
0
2024-Q4
New
10
-
$230.0%$2.37
17

Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used